Imipramine Tillomed

Imipramine Hydrochloride, the active ingredient in Imipramine Tillomed, is a tricyclic antidepressant presented as an oral formulation for oral use. It is used to treat major depressive disorder and related conditions in adults.

GNH USA supplies Imipramine Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imipramine Tillomed, a tricyclic antidepressant, is indicated for several psychiatric conditions.

- Major depressive disorder: alleviates depressive symptoms and improves mood in adult patients. - Depressive episodes associated with bipolar disorder: helps manage the depressive phase of bipolar illness. - Panic disorder: reduces the frequency and severity of panic attacks.

Imipramine Tillomed may cause a range of adverse reactions, some of which are frequent while others are uncommon but serious.

Common Side Effects: - Dry mouth: reduced salivary secretion. - Constipation: slowed gastrointestinal motility. - Blurred vision: transient visual disturbances. - Drowsiness: increased sedation. - Weight gain: gradual increase in body weight. - Urinary retention: difficulty emptying the bladder.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm, especially in patients with pre‑existing heart disease. - Seizures: heightened risk of convulsive episodes. - Severe hypotension: marked drop in blood pressure on standing. - Agranulocytosis: dangerously low white‑blood‑cell count. - Hepatotoxicity: liver enzyme elevation or injury. - Suicidal ideation: emergence or worsening of suicidal thoughts.

Before initiating therapy with Imipramine Tillomed, several safety considerations are recommended.

- Cardiovascular assessment: evaluate heart function, especially in patients with known cardiac disease. - Suicidal monitoring: watch for emergence of suicidal thoughts, particularly early in treatment. - Elderly caution: start at low dose and monitor for anticholinergic effects. - Discontinuation: avoid abrupt cessation to reduce risk of withdrawal symptoms. - Hepatic/renal function: adjust dosing if significant impairment is present. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Imipramine Tillomed can interact with several other medicines; the significance of each interaction varies.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Selective serotonin reuptake inhibitors (SSRIs) or SNRIs: increased serotonin syndrome risk. - Certain anticholinergic agents: additive anticholinergic burden. - Drugs that prolong QT interval: heightened arrhythmia potential.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise imipramine plasma levels. - Antihypertensive agents: possible additive blood‑pressure lowering effect. - CNS depressants (e.g., benzodiazepines, alcohol): enhanced sedation. - Anticholinergic drugs: monitor for excessive dry mouth and constipation. - Herbal supplements (e.g., St. John’s wort): may alter drug metabolism.